Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 08, 2025 04:00 ET | Source: AKAMPION

Stanford University Secures NIH Grant to Advance tiakis Biotech´s Elafin (Tiprelestat) Through a U.S. Phase II Trial in Pulmonary Arterial Hypertension

- Novel, disease-modifying treatment option for Pulmonary Arterial Hypertension (PAH), an orphan indication with a significant unmet medical need Kiel, GERMANY, September 8, 2025 – tiakis Biotech AG...
July 21, 2025 12:30 ET | Source: Custom Market Insights

[Latest] Global Cardiac Tissue Engineering Market Size/Share Worth USD 2,943.92 Million by 2034 at a 16.65% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Austin, TX, USA, July 21, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Cardiac Tissue Engineering Market Size, Trends and Insights By Material...
February 04, 2025 03:30 ET | Source: Custom Market Insights

[Latest] Global Cosmetic Laser Market Size/Share Worth USD 11.6 Billion by 2033 at a 14.7% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)

Austin, TX, USA, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Cosmetic Laser Market Size, Trends and Insights By Product (Ablative Lasers,...
November 04, 2024 06:00 ET | Source: R3 Vascular

FDA Grants R3 Vascular IDE Approval for ELITE-BTK Pivotal Trial of its MAGNITUDE® Drug Eluting Next Generation Bioresorbable Scaffold for Below-the-Knee Peripheral Arterial Disease

MOUNTAIN VIEW, Calif., Nov. 04, 2024 (GLOBE NEWSWIRE) -- R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating...
October 28, 2024 14:36 ET | Source: Sonablate

Sonablate announces first patient enrolled in HIFIVE U.S. clinical trial for ablation of incompetent veins

HIFIVE is a Phase I trial to assess the safety and performance of Sonablate high-intensity focused ultrasound for treating incompetent veins
August 06, 2024 03:30 ET | Source: Custom Market Insights

[Latest] Global Medical Aesthetics Market Size/Share Worth USD 36,168.8 Million by 2033 at a 8.4% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)

Austin, TX, USA, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Medical Aesthetics Market Size, Trends and Insights By Product Type (Aesthetic...
July 09, 2024 14:25 ET | Source: R3 Vascular

R3 Vascular Appoints Josh Smale as its Vice President of Global Clinical and Scientific Affairs

R3 Vascular Inc. is pleased to announce the appointment of Josh Smale as its Vice President of Global Clinical and Scientific Affairs.
May 09, 2024 12:00 ET | Source: R3 Vascular

R3 Vascular Announces $87 Million in Series B Financing and Appoints Christopher M. Owens as new President and CEO

R3 Vascular, Inc. announced the closing of its $87 million Series B financing round and the appointment of a new President and Chief Executive Officer
May 09, 2024 06:30 ET | Source: Teleflex Incorporated

Teleflex Expands Intraosseous Vascular Access Portfolio with New Arrow™ EZ-IO™ Intraosseous Access Procedure Tray

WAYNE, Pa., May 09, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a global leader in medical technologies and pioneer in intraosseous vascular access, today announced the launch of the...
May 08, 2024 09:00 ET | Source: Therini Bio, Inc.

Therini Bio Announces Positive Preclinical Data Supporting the Development of THN391 in Neurodegenerative Ocular Diseases

THN391, a mAb designed to block neuroinflammation triggered by fibrin, demonstrated effectiveness in protecting against vascular and neuronal degeneration